Genome-wide analysis of 439 mass spectrometry-based proteomic profiles in a population of 15,035 Scottish individuals
Open Access
- 9 September 2026
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Abstract
Understanding the genetic architecture of the circulating proteome can help determine if a protein is causally linked to disease. Previous large-scale genome-wide association studies of proteins have mostly been conducted on pre-defined, targeted subsets of the proteome, and have often concentrated on low-abundance proteins, many of which don’t exert their main function in serum. Mass spectrometry-based proteomics facilitates the study of high-abundance proteins and their isoforms, focusing on proteins active in blood. In 15035 individuals from Generation Scotland, we perform genome-wide association studies of 439 highly abundant serum protein groups as identified and quantified by liquid chromatography tandem mass spectrometry. We identify 1553 independent SNP signals for 398 proteins ( P < 1.2×10 −10 ). Two-sample Mendelian Randomisation analyses are applied to test if the 398 proteins with significant SNP signals are causally associated with 79 common causes of morbidity and mortality. We report putative causal associations between 13 proteins and 17 outcomes, including neuropsychiatric and cardiovascular conditions. Large-scale genome-wide analyses of the high-abundance proteome complement targeted approaches for the discovery of causal pathways of disease.Keywords
Funding Information
- Alzheimer's Society (AS-PG-19b-010)
This publication has 78 references indexed in Scilit:
- Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traitsNature Genetics, 2012
- The discovery of α1-antitrypsin and its role in health and diseaseRespiratory Medicine, 2011
- Reduced levels of IgM autoantibodies against N-truncated pyroglutamate Aβ in plasma of patients with Alzheimer's diseaseNeurobiology of Aging, 2011
- On the Development of Plasma Protein BiomarkersJournal of Proteome Research, 2011
- GCTA: A Tool for Genome-wide Complex Trait AnalysisThe American Journal of Human Genetics, 2011
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker DiscoveryPLOS ONE, 2010
- A map of human genome variation from population-scale sequencingNature, 2010
- On the Use of Variance per Genotype as a Tool to Identify Quantitative Trait Interaction Effects: A Report from the Women's Genome Health StudyPLOS Genetics, 2010
- Prostate-specific antigen and prostate cancer: prediction, detection and monitoringNature Reviews Cancer, 2008
- Multiplexed protein measurement: technologies and applications of protein and antibody arraysNature Reviews Drug Discovery, 2006